Peregrine Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Peregrine Capital Management LLC

$3.08 Billion
Q2 2025

A detailed history of Peregrine Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 73,468 shares of AXSM stock, worth $7.73 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

73,468

Previous 59,721 23.02%

Holding current value

$7.73 Million

Previous $6.97 Million 10.11%

% of portfolio

0.25%

Previous 0.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$95.65 - $116.49 $1.31 Million - $1.6 Million	13,747 Added 23.02%	73,468 $7.67 Million
Q1 2025 Apr 25, 2025	SELL	$80.05 - $137.75 $2.2 Million - $3.78 Million	-27,466 Reduced 31.5%	59,721 $6.97 Million
Q4 2024 Jan 31, 2025	BUY	$83.08 - $100.49 $1.27 Million - $1.53 Million	15,258 Added 21.21%	87,187 $7.38 Million
Q3 2024 Oct 24, 2024	SELL	$78.93 - $95.84 $1.22 Million - $1.48 Million	-15,444 Reduced 17.68%	71,929 $6.46 Million
Q2 2024 Jul 29, 2024	BUY	$65.72 - $80.5 $81,361 - $99,659	1,238 Added 1.44%	87,373 $7.03 Million
Q1 2024 Apr 26, 2024	BUY	$69.39 - $97.64 $91,456 - $128,689	1,318 Added 1.55%	86,135 $6.87 Million
Q4 2023 Jan 26, 2024	SELL	$57.42 - $83.61 $360,253 - $524,569	-6,274 Reduced 6.89%	84,817 $6.75 Million
Q3 2023 Oct 19, 2023	SELL	$69.25 - $82.21 $1.14 Million - $1.35 Million	-16,442 Reduced 15.29%	91,091 $6.37 Million
Q2 2023 Jul 26, 2023	SELL	$58.41 - $90.35 $43,690 - $67,581	-748 Reduced 0.69%	107,533 $7.73 Million
Q1 2023 Apr 26, 2023	BUY	$58.39 - $75.0 $694,549 - $892,125	11,895 Added 12.34%	108,281 $6.68 Million
Q4 2022 Jan 10, 2023	SELL	$39.94 - $79.72 $417,492 - $833,313	-10,453 Reduced 9.78%	96,386 $7.43 Million
Q3 2022 Oct 26, 2022	SELL	$36.06 - $69.85 $1.24 Million - $2.41 Million	-34,445 Reduced 24.38%	106,839 $4.77 Million
Q2 2022 Jul 20, 2022	SELL	$21.74 - $46.75 $529,847 - $1.14 Million	-24,372 Reduced 14.71%	141,284 $5.41 Million
Q1 2022 Apr 27, 2022	BUY	$23.7 - $41.39 $1.1 Million - $1.92 Million	46,358 Added 38.86%	165,656 $6.86 Million
Q4 2021 Jan 31, 2022	BUY	$30.7 - $43.36 $103,121 - $145,646	3,359 Added 2.9%	119,298 $4.51 Million
Q3 2021 Nov 02, 2021	SELL	$19.91 - $68.26 $457,850 - $1.57 Million	-22,996 Reduced 16.55%	115,939 $3.82 Million
Q2 2021 Aug 03, 2021	BUY	$50.63 - $73.5 $533,133 - $773,955	10,530 Added 8.2%	138,935 $9.37 Million
Q1 2021 May 11, 2021	SELL	$55.91 - $81.44 $1 Million - $1.46 Million	-17,920 Reduced 12.25%	128,405 $7.27 Million
Q4 2020 Jan 19, 2021	BUY	$66.31 - $86.52 $9.7 Million - $12.7 Million	146,325 New	146,325 $11.9 Million

Others Institutions Holding AXSM

# of Institutions

403

Shares Held

37.3M

Call Options Held

507K

Put Options Held

540K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.51B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Axsome Therapeutics, Inc. Transaction History